Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori

Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori

Abstract Background Clarithromycin-resistance is becoming a global health concern in the treatment of Helicobacter pylori (H. pylori). The mutant prevention concentration (MPC) represent the propensities of antimicrobial agents to select resistant mutants. The concentration range between the minimum...

Full description

Bibliographic Details
Main Authors: Zi-Han Feng, Ling Fan, Jing Yang, Xing-Yue Huo, Yan Guo, Yi Zhang, Chun-Hui Lan
Format: Article
Language:English
Published: BMC 2019-08-01
Series:BMC Microbiology
Subjects:
Helicobacter pylori
Clarithromycin
MPC
MSW
Antibiotic resistance
Online Access:http://link.springer.com/article/10.1186/s12866-019-1558-8

Internet

http://link.springer.com/article/10.1186/s12866-019-1558-8

Similar Items